Stockscreener 앱 받기
2.07
1.90%
-0.04
시간 외 거래:
2.03
-0.04
-1.93%
전일 마감가:
$2.11
열려 있는:
$2.11
하루 거래량:
698.28K
Relative Volume:
0.85
시가총액:
$147.02M
수익:
-
순이익/손실:
$-117.50M
주가수익비율:
-0.8625
EPS:
-2.4
순현금흐름:
$-114.31M
1주 성능:
-11.91%
1개월 성능:
-2.82%
6개월 성능:
-0.96%
1년 성능:
-35.11%
1일 변동 폭
$2.01
$2.13
1주일 범위
$2.01
$2.365
52주 변동 폭
$1.31
$3.8099
엔카르타 Stock (NKTX) Company Profile
명칭
Nkarta Inc
전화
(925) 407-1049
주소
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
NKTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NKTX
Nkarta Inc
|
2.07 | 149.86M | 0 | -117.50M | -114.31M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
엔카르타 Stock (NKTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-15 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-10-09 | 개시 | Rodman & Renshaw | Buy |
| 2024-08-14 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-03-22 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2022-12-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-10-10 | 개시 | Canaccord Genuity | Buy |
| 2022-07-28 | 개시 | Needham | Buy |
| 2022-07-18 | 개시 | SVB Leerink | Outperform |
| 2022-03-11 | 개시 | Raymond James | Outperform |
| 2022-03-08 | 개시 | H.C. Wainwright | Buy |
| 2022-01-06 | 개시 | William Blair | Outperform |
| 2021-11-18 | 개시 | SMBC Nikko | Outperform |
| 2021-07-16 | 개시 | Oppenheimer | Outperform |
| 2020-08-04 | 개시 | Cowen | Outperform |
| 2020-08-04 | 개시 | Evercore ISI | Outperform |
| 2020-08-04 | 개시 | Mizuho | Buy |
| 2020-08-04 | 개시 | Stifel | Buy |
모두보기
엔카르타 주식(NKTX)의 최신 뉴스
Will Nkarta Inc. stock split again soon2025 Market Sentiment & Growth Focused Investment Plans - newser.com
Is it time to cut losses on Nkarta Inc.Market Activity Report & Reliable Volume Spike Alerts - newser.com
Is Nkarta Inc. stock supported by strong fundamentalsIPO Watch & Safe Capital Preservation Plans - newser.com
Nkarta Inc. stock prediction for this weekJuly 2025 Snapshot & Target Return Focused Picks - newser.com
Nkarta Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
Risk adjusted return profile for Nkarta Inc. analyzedBond Market & Capital Protection Trading Alerts - newser.com
Will Nkarta Inc. stock continue upward momentumRisk Management & Community Consensus Stock Picks - newser.com
Real time alert setup for Nkarta Inc. performancePortfolio Performance Summary & Weekly High Potential Stock Alerts - newser.com
Will Nkarta Inc. stock deliver strong dividend growthWeekly Stock Recap & Free Expert Verified Stock Movement Alerts - newser.com
Using Python tools to backtest Nkarta Inc. strategiesQuarterly Performance Summary & Technical Buy Zone Confirmation - newser.com
Will Nkarta Inc. stock gain from government policiesPortfolio Update Summary & Safe Capital Investment Plans - newser.com
Nkarta Inc Stock Analysis and ForecastGrowth vs. Value Investing & Low Cost Market Strategies - earlytimes.in
Weiss Ratings Reaffirms "Sell (D-)" Rating for Nkarta (NASDAQ:NKTX) - MarketBeat
What drives Nkarta Inc stock priceRisk Mitigation Techniques & Low Entry Cost Investments - earlytimes.in
Can machine learning forecast Nkarta Inc. recoveryJuly 2025 Weekly Recap & High Accuracy Investment Signals - newser.com
Nkarta Inc. stock chart pattern explainedProduct Launch & Short-Term Trading Opportunity Alerts - newser.com
Will Nkarta Inc. stock sustain high P E ratiosJuly 2025 Action & Expert Curated Trade Setups - newser.com
Nkarta to Participate in November Investor Conferences - Bluefield Daily Telegraph
Nkarta (NKTX) to Release Earnings on Thursday - MarketBeat
What momentum indicators show for Nkarta Inc. stockTrade Signal Summary & Expert Approved Momentum Ideas - newser.com
Nkarta, Inc. Advances CAR NK Cell Therapy Study for Immune-Mediated Diseases - MSN
Why Nkarta Inc. stock is a must watch in 20252025 Buyback Activity & Fast Momentum Stock Entry Tips - fcp.pa.gov.br
Is Nkarta Inc. stock a defensive play in 2025Weekly Stock Analysis & Community Consensus Trade Signals - fcp.pa.gov.br
엔카르타 (NKTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):